Search Page

1

Cite

Share

Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.

Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD. Chatzizisis YS, et al. Among authors: hatzitolios a. Drug Saf. 2010 Mar 1;33(3):171-87. doi: 10.2165/11319380-000000000-00000. Drug Saf. 2010. PMID: 20158283 Review.

Cite

Share

2

Cite

Share

Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.

Athyros VG, Mikhailidis DP, Kakafika AI, Karagiannis A, Hatzitolios A, Tziomalos K, Ganotakis ES, Liberopoulos EN, Elisaf M. Athyros VG, et al. Among authors: hatzitolios a. Curr Drug Targets. 2007 Mar;8(3):483-8. doi: 10.2174/138945007780058933. Curr Drug Targets. 2007. PMID: 17348840 Review.

Cite

Share

3

Cite

Share

Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?

Athyros VG, Tziomalos K, Mikhailidis DP, Pagourelias ED, Kakafika AI, Skaperdas A, Hatzitolios A, Karagiannis A. Athyros VG, et al. Among authors: hatzitolios a. Expert Opin Pharmacother. 2007 Oct;8(14):2267-77. doi: 10.1517/14656566.8.14.2267. Expert Opin Pharmacother. 2007. PMID: 17927482 Review.

Cite

Share

4

Cite

Share

Advanced glycosylation end products and nutrition--a possible relation with diabetic atherosclerosis and how to prevent it.

Xanthis A, Hatzitolios A, Koliakos G, Tatola V. Xanthis A, et al. Among authors: hatzitolios a. J Food Sci. 2007 Oct;72(8):R125-9. doi: 10.1111/j.1750-3841.2007.00508.x. J Food Sci. 2007. PMID: 17995617 Review.

Cite

Share

5

Cite

Share

Vitamins and stroke: the homocysteine hypothesis still in doubt.

Ntaios GC, Savopoulos CG, Chatzinikolaou AC, Kaiafa GD, Hatzitolios A. Ntaios GC, et al. Among authors: hatzitolios a. Neurologist. 2008 Jan;14(1):2-4. doi: 10.1097/01.nrl.0000253066.85963.aa. Neurologist. 2008. PMID: 18195649 Review.

Cite

Share

6

Cite

Share

Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.

Kosmidou MS, Hatzitolios AI, Adamidou A, Giannopoulos S, Raikos N, Parharidis G, Milionis HJ. Kosmidou MS, et al. Among authors: hatzitolios ai. Am J Hypertens. 2008 Mar;21(3):303-9. doi: 10.1038/ajh.2007.61. Epub 2008 Jan 17. Am J Hypertens. 2008. PMID: 18202666 Clinical Trial.

Cite

Share

7

Cite

Share

Diabetes mellitus and cerebrovascular disease: which are the actual data?

Hatzitolios AI, Didangelos TP, Zantidis AT, Tziomalos K, Giannakoulas GA, Karamitsos DT. Hatzitolios AI, et al. J Diabetes Complications. 2009 Jul-Aug;23(4):283-96. doi: 10.1016/j.jdiacomp.2008.01.004. Epub 2008 Mar 20. J Diabetes Complications. 2009. PMID: 18358748 Review.

Cite

Share

8

Cite

Share

Atherogenesis in renal patients: a model of vascular disease?

Efstratiadis G, Tziomalos K, Mikhailidis DP, Athyros VG, Hatzitolios A. Efstratiadis G, et al. Among authors: hatzitolios a. Curr Vasc Pharmacol. 2008 Apr;6(2):93-107. doi: 10.2174/157016108783955374. Curr Vasc Pharmacol. 2008. PMID: 18393910 Review.

Cite

Share

9

Cite

Share

The role of uric acid in stroke: the issue remains unresolved.

Dimitroula HV, Hatzitolios AI, Karvounis HI. Dimitroula HV, et al. Neurologist. 2008 Jul;14(4):238-42. doi: 10.1097/NRL.0b013e31815c666b. Neurologist. 2008. PMID: 18617849 Review.

Cite

Share

10

Cite

Share

The syndrome of rhabdomyolysis: complications and treatment.

Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. Chatzizisis YS, et al. Eur J Intern Med. 2008 Dec;19(8):568-74. doi: 10.1016/j.ejim.2007.06.037. Epub 2008 Apr 28. Eur J Intern Med. 2008. PMID: 19046720 Review.

Cite

Share